TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Thursday reported second-quarter profit of $1.3 billion.
On a per-share basis, the Tarrytown, New York-based company said it had net income of $12.23. Earnings, adjusted for one-time gains and costs, were $14.29 per share.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $10 per share.
The biopharmaceutical company posted revenue of $4.29 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $3.84 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN
/Space/Rocket%20launching%20into%20space%20by%20BEST%20BACKGROUNDS%20via%20Shutterstock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/Close-up%20shot%20of%20Rivian%20R1T_%20Image%20by%20Trong%20Nguyen%20via%20%20Shutterstock_.jpg)
